Department of Emergency, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Jiangxi, China.
Front Immunol. 2024 Jul 8;15:1417270. doi: 10.3389/fimmu.2024.1417270. eCollection 2024.
Apolipoprotein A-I(ApoA-I) is a member of blood apolipoproteins, it is the main component of High density lipoprotein(HDL). ApoA-I undergoes a series of complex processes from its generation to its composition as spherical HDL. It not only has a cholesterol reversal transport function, but also has a function in modulating the inflammatory response. ApoA-I exerts its anti-inflammatory effects mainly by regulating the functions of immune cells, such as monocytes/macrophages, dendritic cells, neutrophils, and T lymphocytes. It also modulates the function of vascular endothelial cells and adipocytes. Additionally, ApoA-I directly exerts anti-inflammatory effects against pathogenic microorganisms or their products. Intensive research on ApoA-I will hopefully lead to better diagnosis and treatment of inflammatory diseases.
载脂蛋白 A-I(ApoA-I)是血液载脂蛋白的成员,它是高密度脂蛋白(HDL)的主要成分。ApoA-I 从其产生到组成球形 HDL 经历了一系列复杂的过程。它不仅具有胆固醇逆转运功能,而且在调节炎症反应方面具有功能。ApoA-I 主要通过调节免疫细胞(如单核细胞/巨噬细胞、树突状细胞、中性粒细胞和 T 淋巴细胞)的功能发挥抗炎作用。它还调节血管内皮细胞和脂肪细胞的功能。此外,ApoA-I 还可以直接针对病原体或其产物发挥抗炎作用。对 ApoA-I 的深入研究有望为炎症性疾病的诊断和治疗带来更好的效果。